Skip to main content

Table 5 Adverse events

From: A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury

  Placebo Silymarin
(N = 28) (N = 27)
Major adverse events 0 0
Minor adverse events 3 (10.7) 3 (10.7)
• Nausea / vomiting 1 3
• Dizziness 2 0
Total 3 (10.7) 3 (10.7)
  1. Categorical variables reported as N (%)